Avadel Pharmaceuticals (AVDL) Shares Outstanding: 2009-2022
Historic Shares Outstanding for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Sep 2022 value amounting to $60.9 million.
- Avadel Pharmaceuticals' Shares Outstanding rose 3.87% to $60.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $60.9 million, marking a year-over-year increase of 3.87%. This contributed to the annual value of $58.6 million for FY2021, which is 0.38% up from last year.
- Avadel Pharmaceuticals' Shares Outstanding amounted to $60.9 million in Q3 2022, which was up 3.13% from $59.0 million recorded in Q2 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding peaked at $63.5 million during Q2 2020, and registered a low of $42.1 million during Q1 2018.
- Moreover, its 3-year median value for Shares Outstanding was $58.6 million (2021), whereas its average is $58.7 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Shares Outstanding surged by 48.58% in 2020 and then declined by 7.95% in 2021.
- Avadel Pharmaceuticals' Shares Outstanding (Quarterly) stood at $42.7 million in 2018, then grew by 0.48% to $42.9 million in 2019, then soared by 36.04% to $58.4 million in 2020, then increased by 0.38% to $58.6 million in 2021, then climbed by 3.87% to $60.9 million in 2022.
- Its Shares Outstanding stands at $60.9 million for Q3 2022, versus $59.0 million for Q2 2022 and $59.0 million for Q1 2022.